GLP-1 agonists such as Wegovy (semaglutide) and Zepbound (tirzepatide) have demonstrated up to 20% body weight reductions in pivotal trials an efficacy previously thought achievable only through bariatric surgery
white blood cells rid the area of foreign materials and release molecules to coordinate healing
Common Side Effects Gastrointestinal Symptoms : The most frequently reported side effects include nausea, vomiting, diarrhea, and constipation
In most cases, muscle cramps associated with GLP-1 therapy can be managed successfully with hydration, nutritional optimization, and supportive care, allowing patients to continue benefiting from these medications
[GLP-1s] should be used as part of a broader treatment plan that includes lifestyle support, not as a stand-alone solution. The WHO guidelines seem to recognize this complexity